Home
Subscription
December 2024 issue
November 2024 issue
October 2024 issue
September 2024 issue
August 2024 issue
July 2024 issue
June 2024 issue
May 2024 issue
April 2024 issue
April 1, 2024 issue
March 2024 issue
February 2024 issue
January 2024 issue
BACK ISSUES
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
|
2014 Issues
December 2014 Issue
• Feature - With Optimism!
• Appreciation
• New Drug Review: Dulaglutide (Trulicity - Lilly)
• Index for Volume 9, 2014
November 2014 Issue
• Feature - Serious Medication Errors Must be Reported – for Educational and Preventative Purposes!
• New Drug Review: Bazedoxifene acetate/conjugated estrogens (Duavee - Pfizer)
October 2014 Issue
• Feature - Health, Wellness, and Cigarettes
• New Drug Review: Apremilast (Otezla - Celgene)
September 2014 Issue
• Feature - Voters in North Dakota Should Oppose the Challenge to the Pharmacy Ownership Law!
• Chantix Should be Available Without a Prescription from a Pharmacist!
• New Drug Review: Empagliflozin (Jardiance - Boehringer-Ingelheim; Lilly)
August 2014 Issue
• Feature - Hydrocodone, Zohydro ER, Pain Relief, Addiction, and Death—What Are Our Priorities?
• New Drug Review: Albiglutide
(Tanzeum - GlaxoSmithKline)
July 2014 Issue
• Feature - Patients Held Hostage!
Exorbitant Drug Prices Will Result in Rationing of Treatment and Price Controls!
• New Drug Review: Umeclidinium bromide/vilanterol trifenatate (Anoro Ellipta - GlaxoSmithKline)
June 2014 Issue
• Feature - More than 10 Colleges of Pharmacy Will Close in the Next 20 Years! UNLESS . . . . .
• New Therapeutic Agents Marketed in the United States in 2013
May 2014 Issue
• Feature - Bigger Won't Be Better If Pfizer Acquires AstraZeneca! And Tens of Thousands Will Lose Their Jobs
• New Drug Review: Avanafil (Stendra - Auxilium; Vivus)
April 2014 Issue
• Feature - Pharmacy's National Treasure – COMMUNITY PHARMACISTS! But They are Threatened!
• New Drug Review: Dapagliflozin propanediol (Farxiga - Bristol-Myers Squibb; AstraZeneca)
March 2014 Issue
• Feature - Over-The-Counter Drug Monograph System – PAST, PRESENT AND FUTURE
• New Drug Review: Dolutegravir sodium (Tivicay - GlaxoSmithKline; ViiV)
February 2014 Issue
• Feature - Commendation for CVS!
• Commendation for the Pharmacies that Never Sold or have Discontinued the Sale of Tobacco Products!
• The Tipping Point Should Become a Domino Effect!
• Chantix Should be Available Without a Prescription from a Pharmacist!
• New Drug Review: Sofosbuvir (Sovaldi - Gilead)
January 2014 Issue
• Feature - We Will Try Resolutions Again but Pharmacy May Need a Revolution!
• New Drug Review: Vortioxetine hydrobromide (Brintellix - Lundbeck; Takeda)
| |
